Patient Enrolment

Belite Bio Shares Gain On Initiation Of Late-Stage Retinal Disease Study

Tonix Pharmaceuticals Commences Mid-Stage Long COVID Study, Sees Interim Report In H1 2023

Agenus Commences Initial-Stage Advanced Tumors Study

Tonix Pharmaceuticals Commences Mid-Stage Long COVID Study, Sees Interim Report In H1 2023

Agenus Commences Initial-Stage Advanced Tumors Study

Alterity Commences Mid-Stage Neurodegenerative Disorder Study

Kiora Commences Mid-Stage Rare Eye Disease Study

Alterity Commences Mid-Stage Neurodegenerative Disorder Study

Kiora Commences Mid-Stage Rare Eye Disease Study

BioRestorative Shares Fall As Enrolment Initiated in Mid-Stage Chronic Back Pain Drug Study

Cognition Therapeutics Begins Mid-Stage Study Of Neurological Disorder Candidate

Patient Enrolment Recent News

Plus Therapeutics Concludes Enrolment In Initial-Stage Study Of Cerebrospinal Fluid Cancer Setting

Plus Therapeutics (NASDAQ: PSTV) has concluded patient enrolment in the first cohort of the ReSPECT-LM Phase 1/2a dose escalation clinical trial of Rhenium-186 NanoLiposome (186RNL) for the treatment of leptomeningeal metastases (LM).